Key facts
- Notable investors include NRL Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for INREEDI
- ·The full record, as it builds
Funding rounds
No funding rounds for INREEDI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About INREEDI
Developer of radiofrequency-based medical devices designed to enhance precision and safety in surgical and aesthetic procedures. The company offers proprietary low-temperature coagulation technology, Class III certified devices, and high-performance monopolar systems, enabling medical aesthetics professionals and surgeons to perform delicate interventions with greater control, reduced tissue damage, and improved patient outcomes.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2021
- Ownership
- Privately Held (backing)
INREEDI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in INREEDI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on INREEDI in its N-PORT filings yet. We sweep new filings monthly.